Cargando…

P864: CTPS1 IS A NOVEL THERAPEUTIC TARGET IN MYELOMA - SELECTIVE SMALL MOLECULE INHIBITION DELIVERS SINGLE AGENT ACTIVITY AND SYNERGISES WITH ATR INHIBITION

Detalles Bibliográficos
Autores principales: Pfeiffer, C., Beer, P., Asnagli, H., Bolomsky, A., Grandits, A., Schneller, A., Huber, J., Zojer, N., Schreder, M., Parker, A., Ludwig, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428997/
http://dx.doi.org/10.1097/01.HS9.0000846336.64675.44
_version_ 1784779294515396608
author Pfeiffer, C.
Beer, P.
Asnagli, H.
Bolomsky, A.
Grandits, A.
Schneller, A.
Huber, J.
Zojer, N.
Schreder, M.
Parker, A.
Ludwig, H.
author_facet Pfeiffer, C.
Beer, P.
Asnagli, H.
Bolomsky, A.
Grandits, A.
Schneller, A.
Huber, J.
Zojer, N.
Schreder, M.
Parker, A.
Ludwig, H.
author_sort Pfeiffer, C.
collection PubMed
description
format Online
Article
Text
id pubmed-9428997
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94289972022-08-31 P864: CTPS1 IS A NOVEL THERAPEUTIC TARGET IN MYELOMA - SELECTIVE SMALL MOLECULE INHIBITION DELIVERS SINGLE AGENT ACTIVITY AND SYNERGISES WITH ATR INHIBITION Pfeiffer, C. Beer, P. Asnagli, H. Bolomsky, A. Grandits, A. Schneller, A. Huber, J. Zojer, N. Schreder, M. Parker, A. Ludwig, H. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9428997/ http://dx.doi.org/10.1097/01.HS9.0000846336.64675.44 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Pfeiffer, C.
Beer, P.
Asnagli, H.
Bolomsky, A.
Grandits, A.
Schneller, A.
Huber, J.
Zojer, N.
Schreder, M.
Parker, A.
Ludwig, H.
P864: CTPS1 IS A NOVEL THERAPEUTIC TARGET IN MYELOMA - SELECTIVE SMALL MOLECULE INHIBITION DELIVERS SINGLE AGENT ACTIVITY AND SYNERGISES WITH ATR INHIBITION
title P864: CTPS1 IS A NOVEL THERAPEUTIC TARGET IN MYELOMA - SELECTIVE SMALL MOLECULE INHIBITION DELIVERS SINGLE AGENT ACTIVITY AND SYNERGISES WITH ATR INHIBITION
title_full P864: CTPS1 IS A NOVEL THERAPEUTIC TARGET IN MYELOMA - SELECTIVE SMALL MOLECULE INHIBITION DELIVERS SINGLE AGENT ACTIVITY AND SYNERGISES WITH ATR INHIBITION
title_fullStr P864: CTPS1 IS A NOVEL THERAPEUTIC TARGET IN MYELOMA - SELECTIVE SMALL MOLECULE INHIBITION DELIVERS SINGLE AGENT ACTIVITY AND SYNERGISES WITH ATR INHIBITION
title_full_unstemmed P864: CTPS1 IS A NOVEL THERAPEUTIC TARGET IN MYELOMA - SELECTIVE SMALL MOLECULE INHIBITION DELIVERS SINGLE AGENT ACTIVITY AND SYNERGISES WITH ATR INHIBITION
title_short P864: CTPS1 IS A NOVEL THERAPEUTIC TARGET IN MYELOMA - SELECTIVE SMALL MOLECULE INHIBITION DELIVERS SINGLE AGENT ACTIVITY AND SYNERGISES WITH ATR INHIBITION
title_sort p864: ctps1 is a novel therapeutic target in myeloma - selective small molecule inhibition delivers single agent activity and synergises with atr inhibition
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428997/
http://dx.doi.org/10.1097/01.HS9.0000846336.64675.44
work_keys_str_mv AT pfeifferc p864ctps1isanoveltherapeutictargetinmyelomaselectivesmallmoleculeinhibitiondeliverssingleagentactivityandsynergiseswithatrinhibition
AT beerp p864ctps1isanoveltherapeutictargetinmyelomaselectivesmallmoleculeinhibitiondeliverssingleagentactivityandsynergiseswithatrinhibition
AT asnaglih p864ctps1isanoveltherapeutictargetinmyelomaselectivesmallmoleculeinhibitiondeliverssingleagentactivityandsynergiseswithatrinhibition
AT bolomskya p864ctps1isanoveltherapeutictargetinmyelomaselectivesmallmoleculeinhibitiondeliverssingleagentactivityandsynergiseswithatrinhibition
AT granditsa p864ctps1isanoveltherapeutictargetinmyelomaselectivesmallmoleculeinhibitiondeliverssingleagentactivityandsynergiseswithatrinhibition
AT schnellera p864ctps1isanoveltherapeutictargetinmyelomaselectivesmallmoleculeinhibitiondeliverssingleagentactivityandsynergiseswithatrinhibition
AT huberj p864ctps1isanoveltherapeutictargetinmyelomaselectivesmallmoleculeinhibitiondeliverssingleagentactivityandsynergiseswithatrinhibition
AT zojern p864ctps1isanoveltherapeutictargetinmyelomaselectivesmallmoleculeinhibitiondeliverssingleagentactivityandsynergiseswithatrinhibition
AT schrederm p864ctps1isanoveltherapeutictargetinmyelomaselectivesmallmoleculeinhibitiondeliverssingleagentactivityandsynergiseswithatrinhibition
AT parkera p864ctps1isanoveltherapeutictargetinmyelomaselectivesmallmoleculeinhibitiondeliverssingleagentactivityandsynergiseswithatrinhibition
AT ludwigh p864ctps1isanoveltherapeutictargetinmyelomaselectivesmallmoleculeinhibitiondeliverssingleagentactivityandsynergiseswithatrinhibition